- $3.16bn
- $5.45bn
- $532.49m
NYSE ORDER IMBALANCE 53788.0 SHARES ON SELL SIDE
U.S. RESEARCH ROUNDUP-Abiomed, McDonald's, S&P Global
Brief: Automation Anywhere Secures $200 Million In Financing From Silicon Valley Bank And Hercules Capital
Brokerage expects mortgage finance sector's Q3 to be riddled with macro fears
Brief: Provention Bio Announces $125 Million Term Loan Facility With Hercules Capital
Brief: Alladapt Announces Loan Agreement With Hercules Capital
Brief: Atai Life Sciences NV reports Q2 results
Brief: Atai Life Sciences Secures Term Loan Facility For Up To $175 Million From Hercules Capital
Brief: Gritstone Reports Second Quarter 2022 Financial Results And Provides Business Update
U.S. RESEARCH ROUNDUP-Amazon.Com, Charles Schwab, Houlihan Lokey
Hercules Capital Inc reports results for the quarter ended in June - Earnings Summary
Brief: Hercules Capital Reports Second Quarter 2022 Financial Results
Hercules Capital Inc expected to post earnings of 33 cents a share - Earnings Preview
Brief: Hercules Capital Increases Quarterly Cash Distribution To $0.35 Per Share
U.S. RESEARCH ROUNDUP-Altair Engineering, Coinbase Global, GitLab
Brief: Hercules Capital Appoints DeAnne Aguirre To Board Of Directors
Akero Therapeutics pops after Pfizer stake
NASH drug developer Akero rallies on Pfizer investment
Brief: Akero Therapeutics Announces Two Financing Transactions With Pfizer And Hercules Capital